Jack A. Roth

Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wildtype (normal) p53.

J. Roth, Jack A. Roth, 1996, Human gene therapy.

Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report.

R. Arriagada, M. Fukuoka, J. Cox, 1994, Lung cancer.